ENTRY       D06350                      Drug
NAME        Yttrium Y 90 labetuzumab (USAN);
            CES-Cide (TN)
EFFICACY    Antineoplastic, Radioactive agent, Anti-CEA antibody
  TYPE      Monoclonal antibody
COMMENT     Radioimmunotherapy (RAIT) of CEA-expressing tumors for use in the treatment of colorectal cancer
TARGET      CEACAM [HSA:1048 1084 1087 1088 1089 4680 634 90273] [KO:K06499]
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: Ig superfamiy
               CAMs
                CEACAM
                 D06350  Yttrium Y 90 labetuzumab (USAN)
DBLINKS     CAS: 501423-27-4
            PubChem: 47208007
///
